Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Cooper Companies, Inc. (COO:NASDAQ), powered by AI.
The Cooper Companies, Inc. is currently trading at $67.35. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for The Cooper Companies, Inc. on Alpha Lenz.
The Cooper Companies, Inc.'s P/E ratio is 35.2.
“The Cooper Companies, Inc. trades at a P/E of 35.2 (premium valuation) with modest ROE of 4.6%.”
Ask for details →The Cooper Companies Inc. is a global healthcare company that specializes in the production of medical devices, prominently focusing on contact lenses and women's health products. As a key player in the healthcare market, Cooper Companies owns two primary business units: CooperVision and CooperSurgical. CooperVision is renowned for its comprehensive range of soft contact lenses, catering to various vision correction needs such as astigmatism, presbyopia, and myopia control. Meanwhile, CooperSurgical provides innovative products and services focused on women's health, from fertility and lab solutions to surgical tools for gynecological procedures. This diversified business model allows Cooper Companies to impact multiple facets of the healthcare industry, supporting healthcare professionals and enhancing patient care. Headquartered in San Ramon, California, The Cooper Companies is significant in advancing optical technologies and essential medical devices, exemplifying growth within the global healthcare and medical device sectors.
“The Cooper Companies, Inc. trades at a P/E of 35.2 (premium valuation) with modest ROE of 4.6%.”
Ask for details →The Cooper Companies, Inc. (ticker: COO) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 16,000 employees. Market cap is $13.2B.
The current price is $67.35 with a P/E ratio of 35.19x and P/B of 1.6x.
ROE is 4.59% and operating margin is 16.69%. Annual revenue is $4.1B.